A new direct oral anticoagulant APIXA (apixaban) in tablets of 5 mg and 2.5 mg has shown up in Belarusian pharmacies. Until recently, the promising class of direct oral anticoagulants was represented in our country only by dabigatran and rivaroxaban products, while original and generic apixaban was not available. APIXA, the first apixaban generic, forthcoming was possible due to cooperation with our Indian partner, Natco Pharma Ltd. Bioequivalence of APIXA to the original apixaban according to the FDA criteria was confirmed in a clinical study conducted in the United States and Canada. The results of this study were presented in the registration dossier.
-
Meet APIXA – a new NATIVITA’s medicine
2021-11-19 -
NATIVITA OBTAINED PIC/S GMP CERTIFICATE
2021-07-27The NatiVita’s solid dosage forms production area was certified to comply with the rules of the Pharmaceutical Inspection Convention and the Pharmaceutical Inspection Cooperation Scheme (PIC/S).
-
NatiVita presented an analysis of new scientific data on the optimal use of trastuzumab in breast cancer
2020-12-23The medical department of NatiVita has prepared a scientific review “How to optimize trastuzumab adjuvant treatment of early-stage HER2-positive breast cancer”, which was published in the leading Belarusian professional publication in the field of oncology “Oncological Journal” (Oncological Journal 2020; 14(2-3): 131-140).
-
NatiVita is expert at the forum “Clinical Research in the EAEU”
2020-03-26Head of Clinical Research Department NatiVita company Natalia Murashko will prepare a report at the practical forum “Clinical Research in the EAEU” on June in Moscow.
-
“Script of your life” for people living with multiple sclerosis
2020-02-14NatiVita supported an open day organized by the public Association of disabled people “The assistance to patients with multiple sclerosis”.
-
The final event of TALENAVITA 2019 was held as soft-skills festival
2019-12-26On December 21 In Vitebsk was held the SOFT FEST festival, the final event of the 2019 TALENAVITA program, which was attended by more than a hundred high school students and students.
-
The best project in the NatiVita category in the competition of innovative projects was selected
2019-12-23On December 23th the results of the Republican contest of innovative projects were summed up in Minsk and was announced the winner of the special nomination of NatiVita “Biotechnologies and genomics in medicine and pharmaceuticals”.
-
“GOOD” PRIONS: THE EXPERTS CHOSE THE BEST PROJECT TALENAVITA CAMP 2019
2019-08-05For ten days in the Vitebsk region in Lepel township 25 students developed research projects on the theme “ABOUT health: Biotechnology for quality of life”. During the summer science camp boys and girls had to meet and talk to experts from 18 universities of Belarus, national Academy of Sciences of Belarus and leading scientific-practical medical centers.
-
THE COMPETITION OF INNOVATIVE PROJECTS: NATIVITA ANNOUNCED ITS OWN NOMINATION
2019-07-12For the second year in a row, NatiVita supports the Republican competition of innovative projects and announces its own nomination with a prize Fund of two thousand dollars.
-
«WE’RE ROOTING FOR EACH OTHER»
2019-06-22With the support of NatiVita, the national team of Belarus in beach football visited the Republican scientific and practical center of pediatric Oncology, Hematology and immunology. Before the start of the competition at the II European games, the athletes supported the guys who are fighting cancer and played football with them.
-
NATIVITA OPENS THE SECOND SESSION TALENAVITA CAMP
2019-06-11NatiVita company opens the reception of applications for the summer scientific camp TALENAVITA CAMP 2019, which will be held within the framework of the Republican program to support talented young people TALENAVITA.
-
NATIVITA summarized the results of the next stage of technology transfer
2019-05-01NATIVITA summarized the results of the next stage of transfer of manufacturing technologies in the presence of shareholders and honored guests, representatives of the diplomatic mission in the Republic of Belarus.
-
The first Vice Prime Minister of the Republic of Belarus visited the “NATIVITA” factory
2019-04-30On the 17th April Alexander Turchin, first Vice Prime Minister of the Republic of Belarus, visited NATIVITA scientific and manufacturing complex.
-
NATIVITA BECAME A SCIENTIFIC ORGANIZATION
2019-04-19The joint Commission of the National Academy of Sciences and the State Committee of science and technology of the Republic of Belarus awarded NatiVita the status of a scientific organization.
-
NATIVITA WILL SUPPORT THE SCITEEN YOUTH SCIENTIFIC TOURNAMENT
2019-04-08From 8th to 14th April with the support of NatiVita will be held the full-time stage of the scientific and educational project Sciteen that is conscript to involve students in solving applied tasks and developing innovative projects. Our company became the official partner of the event.
-
NatiVita Academic Board selected the best project in biotechnology in the innovational projects contest
2018-12-18On December 26th the results of the 9th National Contest of Innovational projects were announced in Minsk where they named a winner of the special nomination by NatiVita called “Biotechnology and genomics in medicine and pharmaceuticals”.
-
The inspection of the Ministry of Health of Iraq
2018-10-09On the 30 of August the inspection of the Ministry of Health of the Republic of Iraq has visited the manufacturing complex of NatiVita
-
NatiVita has registered drugs in Moldova
2018-10-02NatiVita has registered the first medicinal products in the Republic of Moldova. In the near future, two drugs will immediately receive registration certificates: T-Mab (Trastuzumab) and B-Mab (Bevacizumab). T-Mab and B-Mab are the first drugs registered by NatiVita outside Belarus.
-
Slovak delegation has visited NatiVita
2018-09-27On the 25 of September, NatiVita took part in the first meeting of the Belarusian-Slovak Commission for Cooperation in Science and Technology in Minsk.
-
Medals of the Minsk semi-marathon are in the collection of NatiVita
2018-09-09NatiVita team took part in the semi-marathon, which was held for the fourth time in Minsk.
-
NatiVita in Uzbekistan: we continue cooperation
2018-08-28Representatives of NatiVita took part in the 6th meeting of the Uzbek-Belarusian intergovernmental commission for bilateral cooperation
-
NatiVita registered GLACETAT
2018-08-10Drug for multiple sclerosis treatment
- NatiVita has been granted with a product license for generic drug Glatiramer acetate brand named GLACETAT.
-
Ride4Women
2018-08-09NatiVita became a partner of Ride4Women charity bike ride
On Sunday, July 8th, NatiVita team took part in Ride4Women charity bike ride, which goal was to attract attention to women’s health problems and inform as many people as possible that cancer could be prevented and cured.
-
Respiratory test for cancer screening
2018-07-30On Saturday, July 28, the expert council of the TALENAVITA program selected the best project in the scientific session of TALENAVITA CAMP. The team-winner offered the jury a simple and potentially effective respiratory test for screening the stomach cancer.
-
Belarusian students in the scientific TALENAVITA CAMP
2018-07-18Belarusian students will seek solutions to oncology problems in the scientific camp TALENAVITA CAMP
-
Ride4Women charity bike ride
2018-07-09NatiVita became a partner of Ride4Women charity bike ride.
-
Ride4women: faster than cancer
2018-07-04This Sunday, on July 8th Ride4Women charity bike ride dedicated to treatment of oncological diseases will be held supported by NatiVita.
-
ProBiology: conference for young talents held in Vitebsk
2018-05-28 -
TalenaViта is spinning up
2018-05-13 -
NatiVita registered GLACETAT drug for multiple sclerosis treatment
2018-05-10 -
New markets – new opportunities
2018-04-20 -
TalenaVita: “Northern Star” sparkled over Vitebsk
2018-04-15 -
International conference ISPOR was held in Minsk
2018-04-03 -
NatiVita will be a partner and expert at ISPOR International Conference
2018-03-22 -
NatiVita took part in Arab Health 2018 International Exhibition
2018-02-12